Minimum infectious dose of hepatitis B virus in chimpanzees and difference in the dynamics of viremia between genotype A and genotype C

• Published in: Transfusion (Philadelphia, Pa.) Vol. 48; no. 2; pp. 286 - 294
• Main Authors: Komiya, Yutaka, Katayama, Keiko, Yugi, Hisao, Mizui, Masaaki, Matsukura, Harumichi, Tomoguri, Tetsushi, Miyakawa, Yuzo, Tabuchi, Ayako, Tanaka, Junko, Yoshizawa, Hiroshi
• Format: Journal Article
• Language: English
• Published: Malden, USA Blackwell Publishing Inc 01.02.2008; Blackwell Publishing
• Subjects: Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy; Animals; Biological and medical sciences; Blood. Blood and plasma substitutes. Blood products. Blood cells. Blood typing. Plasmapheresis. Apheresis; DNA, Viral - genetics; Female; Gene Dosage - genetics; Genotype; Hepatitis B - transmission; Hepatitis B - virology; Hepatitis B Antigens - immunology; Hepatitis B virus - genetics; Hepatitis B virus - immunology; Human viral diseases; Indicator Dilution Techniques; Infectious diseases; Male; Medical sciences; Pan troglodytes; Transfusions. Complications. Transfusion reactions. Cell and gene therapy; Viral diseases; Viral hepatitis; Viremia - virology; Virus Replication; Virus; Infection; Transfusion; Hepadnaviridae; Viremia; Viral disease; Orthohepadnavirus; Genotype; Hepatitis B virus
• ISSN: 0041-1132; 1537-2995
• DOI: 10.1111/j.1537-2995.2007.01522.x

BACKGROUND: In planning optimal hepatitis B virus (HBV) blood screening strategies, the minimum infectious dose and early dynamics of HBV need to be determined for defining the window period for HBV DNA as well as for hepatitis B surface antigen (HBsAg). STUDY DESIGN AND METHODS: Pairs of chimpanzees were inoculated with preacute‐phase inocula containing HBV of genotype A or genotype C to determine the minimum infectious dose, and two pairs of chimps infected with the lowest infectious dose of genotypes A and C were followed for HBV markers. RESULTS: The minimum 50 percent chimpanzee infectious dose (CID50) was estimated to be approximately 10 copies for genotype A and for genotype C. In the two chimps inoculated with the lowest infectious dose, the HBV DNA window was 55 to 76 days for genotype  A and 35 to 50 days for genotype C, respectively. The HBsAg window was 69 to 97 days for genotype A and 50 to 64 days for genotype C, respectively. The doubling times of HBV DNA were 3.4 days (95% confidence interval [CI], 2.6‐4.9 days) for genotype A and 1.9 days (95% CI, 1.6‐2.3 days) for genotype C. When comparing the replication velocity of HBV DNA between the two genotypes, the doubling time of genotype C was significantly shorter than that of HBV genotype A (p < 0.01). CONCLUSION: Although the CID50 of approximately 10 copies was similar for the two HBV genotypes, the doubling time and pre‐HBV nucleic acid amplification technology (<100 copies/mL) window period in chimps infected with the lowest infectious dose seemed to be shorter for genotype C than for genotype A.